Shukra Pharmaceuticals informs about outcome of board meeting

03 May 2019 Evaluate

In compliance with Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, Shukra Pharmaceuticals has informed about the outcome of the Meeting of the Board of Directors held on today i.e. 03rd May, 2019 at 01:00 p.m. and concluded on 03:00 p.m. The Company has accepted resignation of Payal Mehta from the post of Chief Financial Officer (CFO) of the Company and appointed Karnik Shah as CFO of the Company.

The above information is a part of company’s filings submitted to BSE.

Shukra Pharma Share Price

73.70 3.05 (4.32%)
01-Nov-2024 18:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1858.70
Dr. Reddys Lab 1258.55
Cipla 1559.20
Lupin 2198.25
Zydus Lifesciences 1004.00
View more..
© 2024 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt.Ltd.